Safety Alerts & Recalls

What does this mean?

Early signs of liver damage can be detected using simple liver function tests. Ensure that your doctor is aware of today's FDA warning, and that your liver function is checked frequently - especially if you have started Natalizumab recently. Also, watch for early signs of jaundice (including yellowing of the eyes and changes in urine color) and report them to your doctor immediately.

Risk of Clinically Significant Liver Injury

The FDA today notified health professionals that it has received reports of clinically significant liver damage from patients taking Natalizumab, with many cases occurring as early as six days after starting treatment.

For more information, please visit: more information here

Source: FDA
Publication Date: 2008-02-27
Last Updated: 2009-12-06

Visit the medication page for the following drugs:

Share your story Share your story! Tell us how MediGuard has helped you or someone you love. Mobile graphic Download the MediGuard Mobile App to manage your prescription and over-the-counter medications, for free. Registration Info Taking multiple medications puts you at risk for possible drug-drug interactions Registration Info Monitor the medical treatment of you and your loved ones.
Back to Consumer Med Safety